[Drug research on norbornan derivatives. 2].
D000433:1-Propanol / Q000627:therapeutic use; D000143:Acids / Q000494:pharmacology; D000438:Alcohols / Q000494:pharmacology; D000588:Amines / Q000494:pharmacology*; D000605:Amino Alcohols / Q000494:pharmacology; D000700:Analgesics / Q000494:pharmacology; D000779:Anesthetics, Local / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000927:Anticonvulsants / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000494:pharmacology; D001712:Biperiden / Q000627:therapeutic use; D002415:Cats; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D004232:Diuretics / Q000494:pharmacology; D004285:Dogs; D004952:Esters / Q000494:pharmacology; D004988:Ethers, Cyclic; D005730:Ganglionic Blockers / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007659:Ketones / Q000494:pharmacology*; D051379:Mice; D009132:Muscles / Q000494:pharmacology; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D010880:Piperidines / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D014665:Vasodilator Agents / Q000494:pharmacology
D000143:Acids; D000438:Alcohols; D000588:Amines; D000605:Amino Alcohols; D000700:Analgesics; D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000959:Antihypertensive Agents; D000697:Central Nervous System Stimulants; D004232:Diuretics; D004952:Esters; D004988:Ethers, Cyclic; D005730:Ganglionic Blockers; D006993:Hypnotics and Sedatives; D007659:Ketones; D010276:Parasympatholytics; D010880:Piperidines; D014665:Vasodilator Agents; D001712:Biperiden; D000433:1-Propanol
Arzneimittelforschung an Norbornan-Derivaten. 2.